Immune and Inflammatory Pathways in Non-Alcoholic Steatohepatitis (NASH). An update [PDF]
Non-alcoholic steatohepatitis (NASH), also known as fatty liver disease (FLD), is a major public health problem. It is considered to be the hepatic manifestation of the metabolic syndrome.
Breaban, Iulia +10 more
core +1 more source
Hepatocarcinoma invadiendo estómago
A. Guzmán-Lepe +2 more
openaire +2 more sources
Establishment and Characterization of MCA23, a Novel Mouse Intrahepatic Cholangiocarcinoma Cell Line
ABSTRACT Introduction Intrahepatic cholangiocarcinoma (ICC) is an aggressive type of malignancy. Recent advancements have highlighted the importance of the tumor immune microenvironment in therapeutic responses and prognosis. However, the lack of a mouse‐derived ICC cell line and current mouse models limit explorations of the TME in ICC.
Yuchao He +12 more
wiley +1 more source
Tromboembolismo tumoral como causa directa de muerte
Introducción: el embolismo tumoral pulmonar es la presencia de acúmulos de células tumorales en las arterias pulmonares arteriolas y capilares pulmonares.
Antonio Belaunde Clausell +2 more
doaj
Impacto de la utilización de hígados de donantes anti-HBc positivo en pacientes trasplantados por hepatitis B [PDF]
El nostre objectiu és avaluar l'impacte de la utilització de fetges de donants anti-HBc positius en pacients trasplantats per hepatitis B, els quals van ser revisats de manera retrospectiva.
García Eliz, Marcia +4 more
core
The article underscores the promising future perspectives of utilizing agro‐industrial waste, envisioning sustainable production processes, and meeting the increasing demand for environmentally friendly and health‐promoting products. ABSTRACT The growing imperative for increased food production has propelled an example alteration in the perception of ...
Fakhar Islam +9 more
wiley +1 more source
Análisis retrospectivo del estadio tumoral al diagnóstico del Hepatocarcinoma en el área oeste de Valladolid [PDF]
El hepatocarcinoma (CHC) es un problema médico relevante por su elevada mortalidad. La mayoría presenta una cirrosis hepática subyacente. En España el VHC constituye el principal factor de riesgo.
López Miñarro, Ignacio Manuel +1 more
core
Therapeutic Potential of Saikosaponins in MASLD and Cross‐Organ Protection: A Research Update
This review systematically outlines the multi‐target mechanisms of Saikosaponins (SSs) against MASLD, encompassing the regulation of lipid metabolism, insulin resistance, and inflammatory response. Furthermore, it highlights their novel cross‐organ protective effects on the cardiovascular, renal, and central nervous systems, providing therapeutic ...
Jiayao Xiong +5 more
wiley +1 more source
A clinical perspective of the link between metabolic syndrome and hepatocellular carcinoma
François Cauchy, Jacques BelghitiHPB and Liver Transplantation Unit, Hôpital Beaujon, Assistance Publique-Hôpitaux de Paris, Clichy, FranceAbstract: Metabolic syndrome (MS), which is defined as a constellation of clinico-biological ...
Cauchy F, Belghiti J
doaj
Resultados a corto y largo plazio del tratamiento quirúrgiico del hepatocarcinoma [PDF]
El hepatocarcinoma (HCC) es una causa importante de mortalidad en pacientes con cirrosis. El tratamiento quirúrgico es de elección en pacientes seleccionados con buena función hepática y una alternativa sólida frente al trasplante. El objetivo de nuestro
Martínez Casals, Ana +1 more
core

